Training Response Inhibition to Obesogenic Foods
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04659837 |
|
Recruitment Status :
Completed
First Posted : December 9, 2020
Last Update Posted : December 9, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Inhibitory Control Training Gameifaction | Behavioral: No-Added-Sugar Diet | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 125 participants |
| Allocation: | Randomized |
| Intervention Model: | Factorial Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Treatment |
| Official Title: | Reducing Cancer Risk by Training Response Inhibition to Obesogenic Foods |
| Actual Study Start Date : | June 1, 2016 |
| Actual Primary Completion Date : | August 7, 2019 |
| Actual Study Completion Date : | December 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Inhibitory Control Training
Active Inhibitory Control Training vs. Sham Inhibitory Control Training
|
Behavioral: No-Added-Sugar Diet
All participants received a no-added-sugar dietary intervention and followed the diet during the course of the study. |
|
Gameification
Gameified elements added vs. No gameified elements added
|
Behavioral: No-Added-Sugar Diet
All participants received a no-added-sugar dietary intervention and followed the diet during the course of the study. |
- Weight [ Time Frame: 8 weeks ]
- Sweets consumption [ Time Frame: 8 weeks ]
- Inhibitory control in response to high-sugar foods [ Time Frame: 8 weeks ]Inhibitory control in response to high-sugar foods is measured via performance (i.e., speed of inhibiting prepotent responses to high-sugar food stimuli) on the daily inhibitory control training (i.e., Go/No-Go) task.
- Compliance with daily inhibitory control training prescription [ Time Frame: 8 weeks ]Compliance with completing the daily inhibitory control training prescription will be measured as the number of days the task was completed out of the total number of days it was prescribed.
- Enjoyment of the daily training task [ Time Frame: 8 weeks ]Enjoyment and acceptability of the inhibitory control training will be assessed using self-report. Participants will be asked to rate how 'fun' and 'boring' the training was on a Likert scale.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- BMI 25-50
- Baseline consumption of ≥ 3 servings/day of high-sugar foods
Exclusion Criteria:
- Medical or psychiatric conditions that could interfere with the ability to comply with diet recommendations,
- pregnancy (or planning to become pregnant in the next 12 months) or current breastfeeding,
- a history of bariatric surgery,
- weight loss of five percent or more within the last six months
- beginning or changing a dosage of a weight-affecting medication within the last three months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04659837
| United States, Pennsylvania | |
| Drexel University | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Responsible Party: | Drexel University |
| ClinicalTrials.gov Identifier: | NCT04659837 |
| Other Study ID Numbers: |
R21CA191859 ( U.S. NIH Grant/Contract ) |
| First Posted: | December 9, 2020 Key Record Dates |
| Last Update Posted: | December 9, 2020 |
| Last Verified: | December 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

